Codexis (CDXS) vs Comstock (LODE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Codexis (CDXS) has outperformed Comstock (LODE) over the past year, losing 34.4% versus a loss of 60.9%. Over five years, LODE leads with a -92.4% price change compared with -97.2% for CDXS. Codexis is the larger company by market cap ($110.7 million vs $100.4 million), about 1.1 times the size.
Codexis converts more of its revenue into profit, with a net margin of -62.5% versus -2772.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDXS | LODE |
|---|---|---|
| Share price | $1.01 | $1.32 |
| Market cap | $110.69M | $100.39M |
| 1-day change | -3.81% | -2.94% |
| YTD return | -38.04% | -64.89% |
| 1-year return | -34.42% | -60.95% |
| 5-year return | -97.24% | -92.41% |
| EPS (TTM) | $-0.18 | $-0.72 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $70.39M | $1.55M |
| Revenue growth (YoY) | +18.61% | -48.48% |
| Net income (latest FY) | $-43.97M | $-43.08M |
| Gross margin | 86.73% | -69.07% |
| Operating margin | -59.30% | -2455.22% |
| Net margin | -62.47% | -2772.34% |
| 52-week high | $2.98 | $4.98 |
| 52-week low | $0.90 | $1.24 |
| Distance from 52-week high | -66.11% | -73.49% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +507.92% | — |
| Average volume | 918.15K | 1.51M |
| Shares outstanding | 109.60M | 76.06M |
| Employees | 146 | 45 |
| Sector | Industrials | Industrials |
| Industry | Major Chemicals | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CDXS has outperformed LODE by 26.5 percentage points over the past year.
- Codexis is more profitable, keeping -62.5 cents of every revenue dollar as net income versus -2772.3 cents for Comstock.
- Codexis grew revenue faster in its latest fiscal year (+18.61% vs -48.48%).
About Codexis
CDXS stock →Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
Industrials · Major Chemicals · 146 employees
About Comstock
LODE stock →Comstock Inc. commercializes technologies, systems, and supply chains that extract, process, and convert under-utilized waste and natural resources into clean energy and clean energy supporting products in the United States.
Industrials · Major Chemicals · 45 employees
CDXS vs LODE FAQ
Which is bigger, Codexis or Comstock?
Codexis (CDXS) is larger, with a market capitalization of $110.69M compared with $100.39M for Comstock (LODE).
Which stock has performed better over the past year, CDXS or LODE?
CDXS returned -34.42% over the past 12 months, compared with -60.95% for LODE (price return, excluding dividends). Past performance does not predict future results.
Are Codexis and Comstock in the same industry?
Yes. Both are classified in the Major Chemicals industry within the Industrials sector.